Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, United Kingdom.
Department of Mathematics and Statistics, University of Strathclyde, Livingstone Tower, 26 Richmond Street, Glasgow G1 1XH, United Kingdom.
Eur J Pharm Biopharm. 2023 Dec;193:58-73. doi: 10.1016/j.ejpb.2023.10.017. Epub 2023 Oct 25.
Intestinal drug solubility is a key parameter controlling absorption after the administration of a solid oral dosage form. The ability to measure fed state solubility in vitro is limited and multiple simulated intestinal fluid recipes have been developed but with no consensus which is optimal. This study has utilised nine bioequivalent simulated fed intestinal media recipes that cover over 90% of the compositional variability of sampled fed human intestinal fluid. The solubility of 24 drugs (Acidic; furosemide, ibuprofen, indomethacin, mefenamic acid, naproxen, phenytoin, piroxicam, valsartan, zafirlukast: Basic; aprepitant, atazanavir, bromocriptine, carvedilol, dipyridamole, posaconazole, tadalafil: Neutral; acyclovir, carbamazepine, felodipine, fenofibrate, griseofulvin, itraconazole, paracetamol, probucol) has been assessed to determine if structured solubility behaviour is present. The measured solubility behaviour can be split into four categories and is consistent with drug physicochemical properties and previous solubility studies. For acidic drugs (category 1) solubility is controlled by media pH and the lowest and highest pH media identify the lowest and highest solubility in 90% of cases. For weakly acidic, basic and neutral drugs (category 2) solubility is controlled by media pH and total amphiphile concentration (TAC), a consistent solubility pattern is evident with variation related to individual drug media component interactions. The lowest and highest pH × TAC media identify the lowest and highest solubility in 70% and 90% of cases respectively. Four drugs, which are non-ionised in the media systems (category 3), have been identified with a very narrow solubility range, indicating minimal impact of the simulated media on solubility. Three drugs exhibit solubility behaviour that is not consistent with the remainder (category 4). The results indicate that the use of two bioequivalent fed intestinal media from the original nine will identify in vitro the maximum and minimum solubility values for the majority of drugs and due to the media derivation this is probably applicable in vivo. When combined with a previous fasted study, this introduces interesting possibilities to measure a solubility range in vitro that can provide Quality by Design based decisions to rationalise drug and formulation development. Overall this indicates that the multi-dimensional media system is worthy of further investigation as in vitro tool to assess fed intestinal solubility.
肠道药物溶解度是控制口服固体制剂给药后吸收的关键参数。在体外测量进食状态下溶解度的能力受到限制,已经开发出多种模拟肠液配方,但尚无最佳配方的共识。本研究利用了 9 种生物等效的模拟进食肠液配方,这些配方涵盖了采样的进食人类肠液中超过 90%的组成变异性。评估了 24 种药物(酸性:呋塞米、布洛芬、吲哚美辛、甲芬那酸、萘普生、苯妥英、吡罗昔康、缬沙坦、扎鲁司特;碱性:阿瑞匹坦、阿扎那韦、溴隐亭、卡维地洛、双嘧达莫、泊沙康唑、他达拉非;中性:阿昔洛韦、卡马西平、非洛地平、非诺贝特、灰黄霉素、伊曲康唑、对乙酰氨基酚、普罗布考)的溶解度,以确定是否存在结构化的溶解度行为。测量的溶解度行为可分为四类,与药物物理化学性质和先前的溶解度研究一致。对于酸性药物(类别 1),溶解度受介质 pH 值控制,最低和最高 pH 值介质在 90%的情况下确定最低和最高溶解度。对于弱酸性、碱性和中性药物(类别 2),溶解度受介质 pH 值和总两亲物浓度(TAC)控制,存在一致的溶解度模式,变化与个别药物介质成分相互作用有关。最低和最高 pH×TAC 介质在 70%和 90%的情况下分别确定最低和最高溶解度。已经确定了 4 种在介质系统中不电离的药物(类别 3),其溶解度范围很窄,表明模拟介质对溶解度的影响很小。有 3 种药物的溶解度行为与其他药物不一致(类别 4)。结果表明,使用原始 9 种生物等效的进食肠液中的两种将确定大多数药物的体外最大和最小溶解度值,并且由于介质的推导,这可能适用于体内。当与以前的空腹研究结合使用时,这为测量体外溶解度范围提供了有趣的可能性,该范围可以提供基于质量设计的决策,以合理化药物和制剂开发。总体而言,这表明多维介质系统值得进一步研究,作为评估进食肠液溶解度的体外工具。